Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities

v3.23.3
Note 8 - Accrued Liabilities
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8.

Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

   

September 30, 2023

   

December 31, 2022

 

Accrued compensation

  $ 570     $ 667  

Accrued research and other professional fees

    418       215  

Accrued clinical trial costs

    231       472  

Accrued other liabilities

    8       11  

Total accrued liabilities

  $ 1,227     $ 1,365